Logo image
Ebola virus skin infections: defining viral entry, trafficking, and tropism
Dissertation   Open access

Ebola virus skin infections: defining viral entry, trafficking, and tropism

Paige Taylor Richards
University of Iowa
Doctor of Philosophy (PhD), University of Iowa
Autumn 2025
DOI: 10.25820/etd.008204
pdf
Paige Richards Thesis Final with edits10.93 MBDownloadView
Open Access

Abstract

Ebola virus (EBOV) is a highly pathogenic filovirus that causes severe hemorrhagic fever in humans. While transmission is typically attributed to direct contact with bodily fluids, the contribution of peripheral tissues such as the skin to EBOV pathogenesis and transmission remains poorly defined. During the 2014–2016 West Africa outbreak, anecdotal reports linked numerous cases to participation in traditional funeral rites, suggesting the possibility that EBOV may persist on or within the skin even after death. This dissertation investigates the role of skin as a site of EBOV infection, replication, and potential viral shedding. Using ex vivo human skin explants, I demonstrate that EBOV traffics through the explant from the dermis to the epidermis, productively infecting dermal immune cells, stromal cells, and basal keratinocytes. Viral RNA and infectious virus were also detected at the apical surface of the epidermis, suggesting that skin may serve as an unrecognized source of person-to-person transmission. These findings were supported in non-human primates and mouse models of infection. Additionally, infection of the mouse model revealed patterns of focal viral localization within dermal layers —supporting nonuniform spread —and around appendageal structures, including hair follicles and sebaceous glands. Despite the presence of EBOV RNA and antigen in skin that is distal to the site of infection, inflammatory gene expression in these tissues remained unexpectedly low. This contrasted sharply with the strong inflammatory responses observed in visceral tissues from the same animals, suggesting that EBOV may actively dampen or evade immune responses in the skin, allowing replication to proceed with minimal inflammation, particularly at distal sites. Notably, using a BSL2-compatible model virus (rVSV/EBOV GP), infectious virus was detectable at the surface of mouse skin distal to the site of injection, even in the absence of rash. Critically, this suggest that viral shedding may occur prior to or without visible skin involvement. Further, mechanistic studies revealed that the phosphatidylserine receptor AXL is required for efficient skin infection when virus is applied topically and is required for optimal keratinocyte and skin fibroblast infection. However, systemic viral dissemination was not dependent upon AXL expression as titers were unchanged in AXL–/– mice. This suggests that topical EBOV infection can drive systemic dissemination independently of keratinocyte-dependent infection. These findings support a model in which EBOV spreads through the skin not diffusely, but in highly focal patterns that may evade detection yet permit viral egress. In addition to defining skin as a site of viral replication and shedding, I also show that skin exposure can elicit protective immune responses. Mice exposed to EBOV via the skin developed robust GP-specific antibody responses even in the absence of productive systemic infection, suggesting that the skin may serve as a viable route for vaccine delivery. Together, these findings establish the skin as a dynamic and underappreciated interface for EBOV transmission, replication, and immune activation. This work redefines the cutaneous landscape of EBOV pathogenesis and highlights novel pathways of surface shedding and viral entry with direct implications for transmission risk and countermeasure development.

Details

Metrics

1 Record Views
Logo image